SIX Financial Information

Enter Ticker Symbol:

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Nature's Sunshine Products, Inc. (NATR : NSDQ)

• Company Description

Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Number of Employees: 819

• Price / Volume Information

Yesterday's Closing Price: $15.62 Daily Weekly Monthly

20 Day Moving Average: 113,738 shares

Shares Outstanding: 18.46 (millions)

Market Capitalization: $288.39 (millions)

Beta: 1.14

52 Week High: $18.06

52 Week Low: $10.81

Short Interest Ratio:

% Price Change % Price Change Relative to S&P 500

4 Week 8.10% 4.39%

12 Week 32.15% 11.52%

Year To Date 6.55% -0.03%

• Address & Contact Information

Street Address Phone / Fax Email Address Web URL

2901 WEST BLUEGRASS BOULEVARD SUITE 100
-
LEHI,UT 84043
USA ph: 801-341-7900
fax: 801-342-4305 natr@gatewayir.com http://www.naturessunshine.com

• General Corporate Information

Officers

Terrence O. Moorehead - Chief Executive Officer and Director
Richard D. Moss - Chairman of the Board and Director
L. Shane Jones - Chief Financial Officer and Executive Vice Preside
Jonathan D. Lanoy - Senior Vice President and Chief Accounting Officer
Steven J. Fasching - Director

Peer Information

Nature's Sunshine Products, Inc. (GSAC)
Nature's Sunshine Products, Inc. (CASI)
Nature's Sunshine Products, Inc. (ALCD.)
Nature's Sunshine Products, Inc. (OMNN)
Nature's Sunshine Products, Inc. (CGPI.)
Nature's Sunshine Products, Inc. (CATX)

Industry / Sector / Ticker Info

Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 639027101
SIC: 2834

Fiscal Year

Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25

Share - Related Items

Shares Outstanding: 18.46
Most Recent Split Date: 3.00 (1.50:1)
Beta: 1.14
Market Capitalization: $288.39 (millions)

• EPS Information    • Dividend Information

Analyst Coverage: No Dividend Yield: 0.00%

Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00

Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00

Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00

Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00

Next EPS Report Date: 08/14/25

• Fundamental Ratios

P/E

Current FY Estimate: -
Trailing 12 Months: 26.47
PEG Ratio: -

Price Ratios

Price/Book: 1.72
Price/Cash Flow: 12.50
Price / Sales: 0.63

EPS Growth

vs. Year Ago Period: 108.33%
vs. Previous Quarter: -%

Sales Growth

vs. Year Ago Period: 2.03%
vs. Previous Quarter: -4.19%

ROE

06/30/25 - -
03/31/25 - 6.98
12/31/24 - 5.54

ROA

06/30/25 - -
03/31/25 - 4.63
12/31/24 - 3.66

Current Ratio

06/30/25 - -
03/31/25 - 2.41
12/31/24 - 2.44

Quick Ratio

06/30/25 - -
03/31/25 - 1.50
12/31/24 - 1.54

Operating Margin

06/30/25 - -
03/31/25 - 2.47
12/31/24 - 1.95

Net Margin

06/30/25 - -
03/31/25 - 2.22
12/31/24 - 1.69

Pre-Tax Margin

06/30/25 - -
03/31/25 - 4.57
12/31/24 - 4.06

Book Value

06/30/25 - -
03/31/25 - 9.11
12/31/24 - 8.71

Inventory Turnover

06/30/25 - -
03/31/25 - 2.08
12/31/24 - 2.10

Debt-to-Equity

06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00

Debt-to-Capital

06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00

Powered by Zacks Investment Research ©